Italia markets closed

Stryker Corporation (SYK)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
275,57-0,59 (-0,21%)
Al 12:04PM EDT. Mercato aperto.

Stryker Corporation

2825 Airview Boulevard
Kalamazoo, MI 49002
United States
269 385 2600

SettoreMedical Devices
Impiegati a tempo pieno43.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Kevin A. LoboChairman & CEO2,97M8,91M1965
Mr. Timothy J. ScannellPres & COO1,54M22,71M1965
Mr. Glenn S. BoehnleinVP & CFO1,28MN/D1962
Mr. Robert S. FletcherVP & Chief Legal Officer895,89kN/D1971
Mr. Viju S. MenonGroup Pres of Global Quality & Operations1,15MN/D1968
Mr. William E. Berry Jr.VP & Chief Accounting OfficerN/DN/D1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementN/DN/DN/D
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerN/DN/DN/D
Mr. Preston WellsVP of Investor RelationsN/DN/DN/D
Ms. Dana S. McMahonVP & Chief Compliance OfficerN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Governance aziendale

L'ISS Governance QualityScore di Stryker Corporation al 1 luglio 2021 è 5. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 8; diritti degli azionisti: 4; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.